CD8 marks a subpopulation of lung-derived dendritic cells with differential responsiveness to viral infection and toll-like receptor stimulation.
An increasing number of studies suggest that individual subsets of dendritic cells (DC) exhibit distinct capabilities with regard to the generation of the adaptive immune response. In this study, we evaluated the properties of a relatively unexplored DC subset present in the lung-draining mediastinal lymph node. This subset expresses the airway dendritic cell marker CD103 together with CD8. These DC were of interest given that our previous studies using a model of respiratory infection with vaccinia virus revealed a distinct difference in the ability of CD103(+) DC to prime T cells that correlated inversely with the expression of CD8, suggesting a differential role of these DC in the context of respiratory virus infection. To expand our understanding of the role of this DC population, we performed analyses to elucidate the phenotype, migratory capacity, responsiveness to innate stimuli, and priming capacity of CD8(+) CD103(+) DC. We found that expression of surface markers on these DC was similar to that of CD8(-) CD103(+) DC, supporting their close relationship. Further, the two DC types were similar with regard to antigen uptake. However, although both CD103(+) subsets originated from the lung, CD8-bearing CD103(+) DC appeared in the lymph node with delayed kinetics following virus infection. While this subset exhibited increased responsiveness to a number of Toll-like receptor (TLR) agonists, their response to infection was virus specific, demonstrating poor responsiveness to vaccinia virus infection but robust maturation following infection with parainfluenza virus 5 or influenza virus. These findings show that CD8 marks a population of lung airway-derived DC with distinct migratory and maturation responses that likely contribute differentially to the immune response depending on the infecting pathogen.
Department of Microbiology and Immunology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
Nicole M
NM
Beauchamp
Rama D
RD
Yammani
Martha A
MA
Alexander-Miller
D000818:Animals; D015703:Antigens, CD / Q000096:biosynthesis; D016827:CD8 Antigens / Q000096:biosynthesis*; D002465:Cell Movement; D003713:Dendritic Cells / Q000166:cytology*; D005434:Flow Cytometry / Q000379:methods; D039001:Integrin alpha Chains / Q000096:biosynthesis; D007700:Kinetics; D008168:Lung / Q000378:metabolism*; D008213:Lymphocyte Activation; D051379:Mice; D008810:Mice, Inbred C57BL; D010873:Pinocytosis; D051193:Toll-Like Receptors / Q000378:metabolism*; D014615:Vaccinia / Q000378:metabolism / Q000821:virology; D014616:Vaccinia virus / Q000378:metabolism; D014777:Virus Diseases / Q000378:metabolism*
D015703:Antigens, CD; D016827:CD8 Antigens; D039001:Integrin alpha Chains; D051193:Toll-Like Receptors; C091367:alpha E integrins